Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions

Saivaroon Gajagowni, Steven Hopkins, Yusuf Qadeer, Salim S. Virani, Job A.J. Verdonschot, Catherine C. Coombs, Christopher I. Amos, Kevin T. Nead, Siddhartha Jaiswal, Chayakrit Krittanawong

Research output: Contribution to journalReview articlepeer-review

Abstract

Clonal hematopoiesis of indeterminate potential (CHIP) is a well-studied phenomenon in hematologic malignancies. With advancements in gene sampling and analysis and the use of large cohort studies, CHIP has recently been linked to cardiovascular disease (CVD). The relationship between CHIP and CVD appears to be bidirectional, with traditional risk factors for cardiovascular disease increasing the mutation burden in CHIP, and CHIP itself effecting the incidence or prognosis of a variety of CVD. The purpose of this review is to understand the epidemiology, risk factors, and pathogenesis of CHIP in the context of various CVD conditions.

Original languageEnglish
JournalProgress in Cardiovascular Diseases
DOIs
Publication statusAccepted/In press - 2024

Keywords

  • Atherosclerosis
  • Cardiovascular complications
  • CHIP
  • Clonal hematopoiesis of indeterminate potential

Fingerprint

Dive into the research topics of 'Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions'. Together they form a unique fingerprint.

Cite this